Certified by Founder
Lodge
Cytospire Therapeutics Ltd
start up
- 07/05/2026
- Series A
- $82,984,705
Cytospire Therapeutics is developing a portfolio of next generation immune cell engagers
- Industry Biotechnology Research
- Website https://www.cytospire.com/
- LinkedIn https://www.linkedin.com/company/cytospire-therapeutics-ltd/
Related People
Natalie MountFounder
United Kingdom -
London, England
Immuno-Oncology
Cell and Gene Therapy
Biotech leadership
Preclinical Development
Translational Medicine
Clinical Development
Forage | $40,000,000 | (Jun 5, 2026)
InCharge Energy | $46,000,000 | (Jun 5, 2026)
Oak Hill Bio | $32,500,000 | (Jun 5, 2026)
ZutaCore | $100,000,000 | (Jun 5, 2026)
Terra AI | $20,000,000 | (Jun 5, 2026)
Town | $55,000,000 | (Jun 5, 2026)
Lassie | $35,000,000 | (Jun 5, 2026)
OFFROAD | $7,000,000 | (Jun 5, 2026)
Shifters | $10,200,000 | (Jun 5, 2026)
Quobly | $133,545,475 | (Jun 5, 2026)
Scispot | $8,000,000 | (Jun 5, 2026)
Scotch | $20,000,000 | (Jun 5, 2026)